KfW

KfW, established in 1948, is a state-owned investment and development bank based in Frankfurt, Germany. As the promotional bank of the Federal Republic of Germany, it operates through several segments, offering a wide range of financing and investment services. KfW supports small and medium-sized businesses, entrepreneurship, housing, infrastructure, education, and export finance, both domestically and internationally. It also promotes sustainable development and provides funding for projects that enhance economic, social, and ecological conditions. Additionally, KfW Capital, a subsidiary established in 2018, invests in German and European venture capital and venture debt funds, adhering to Environmental Social Governance (ESG) principles.

Jochen Eichmann

Head, Venture Tech Growth Financing

Richard Eisenbach

CFO

Jörg Goschin Ph.D

Founder, Senior Managing Director and Co-CEO

Martin Neumann

Senior Investment Manager

Alexander Thees

Co-CEO and Senior Managing Director

Past deals in DACH

CryoTherapeutics

Series B in 2024
CryoTherapeutics GmbH, founded in 2009 and based in Cologne, Germany, specializes in the development of a proprietary cryotherapy system aimed at treating coronary artery disease, a major cause of heart attacks. The company focuses on demonstrating the clinical benefits and ensuring the safety and efficacy of cryoenergy in the cardiovascular system. Its novel catheter system utilizes cryo energy to treat and prevent heart attacks, offering a promising approach to addressing the challenges posed by diseased coronary arteries. Through its early-stage commercialization efforts, CryoTherapeutics aims to enhance treatment options for heart surgeons and improve patient outcomes in cardiovascular health.

Everphone

Debt Financing in 2024
Everphone GmbH, founded in 2016 and based in Berlin, Germany, specializes in the rental of smartphones and tablets for employees within organizations. The company offers a comprehensive solution that includes device procurement, logistics, mobile device management, and hardware advisory services. Through its proprietary software platform, Everphone enables employees to select and borrow mobile devices, streamlining the process for companies to provide necessary technology without straining their internal IT resources. In addition to its rental services, Everphone also manages the repair, replacement, and exchange of old or damaged devices, ensuring that organizations maintain an efficient and updated mobile device ecosystem.

Vectoflow

Series A in 2023
Vectoflow GmbH, founded in 2014 and based in Gilching, Germany, specializes in the manufacture of fluid-dynamic metrology devices. These devices are designed for precise measurement of fluid flow and dynamics, offering both standardized and customized solutions. Vectoflow's products measure static and total pressure, velocity, and angle of attack of a flow, catering to industries such as motorsport, aviation, turbine machine development, and research. The company's probes are adaptable to various customer requirements in terms of geometry, size, and material, ensuring robustness and reliability even under demanding environmental conditions.

Electrochaea

Series D in 2022
Electrochaea GmbH is a German company specializing in the development and commercialization of innovative power-to-gas energy storage technology. Founded in 2010 and headquartered in Planegg, Germany, with additional facilities in Denmark and California, Electrochaea's proprietary biocatalytic process converts low-cost electricity and carbon dioxide into pipeline-grade renewable methane, the primary component of natural gas. This technology enables the efficient storage of renewable energy generated from sources like wind and solar, facilitating grid balancing and carbon recycling. By converting stranded electricity into renewable gas, Electrochaea provides a solution for utility-scale energy storage and supports the decarbonization of transportation and natural gas grids. The company aims to enhance existing infrastructure for energy transmission and contribute to a more sustainable energy landscape.

Uniper

Post in 2022
Uniper is an international energy company headquartered in Düsseldorf, Germany, with approximately 11,000 employees. Established on January 1, 2016, following the separation of E.ON's fossil fuel assets, Uniper focuses on energy generation and trading. The company operates through three main segments: European Generation, Global Commodities, and Russian Power Generation. The European Generation segment encompasses a diverse portfolio, including coal, gas, oil, and combined heat and power plants, as well as hydroelectric, nuclear, biomass, and renewable energy facilities. The Global Commodities segment centralizes the company's energy trading activities, while the Russian Power Generation segment oversees its power generation operations within Russia. Through its integrated approach, Uniper combines advanced technology and expertise to meet the evolving needs of the energy market.

Electrochaea

Venture Round in 2021
Electrochaea GmbH is a German company specializing in the development and commercialization of innovative power-to-gas energy storage technology. Founded in 2010 and headquartered in Planegg, Germany, with additional facilities in Denmark and California, Electrochaea's proprietary biocatalytic process converts low-cost electricity and carbon dioxide into pipeline-grade renewable methane, the primary component of natural gas. This technology enables the efficient storage of renewable energy generated from sources like wind and solar, facilitating grid balancing and carbon recycling. By converting stranded electricity into renewable gas, Electrochaea provides a solution for utility-scale energy storage and supports the decarbonization of transportation and natural gas grids. The company aims to enhance existing infrastructure for energy transmission and contribute to a more sustainable energy landscape.

Productsup

Debt Financing in 2021
Productsup GmbH, founded in 2010 and based in Simmelsdorf, Germany, operates a cloud-based software platform specializing in product data management. As a leader in the product-to-consumer (P2C) segment, the company provides a comprehensive range of solutions that streamline commerce across various channels. Its platform facilitates feed management, product content syndication, marketplace experiences, and the onboarding of sellers and vendors. Productsup enables clients to structure, analyze, and edit product data effectively, allowing for the creation of optimized product feeds tailored to specific channels. The company processes over two trillion products monthly, serving more than 900 brands, including prominent names like IKEA and Sephora, and handles more data requests each month than Google’s consumer search service. Through its innovative approach, Productsup significantly enhances online visibility and overall performance for its clients in the competitive digital marketplace.

Cleverciti

Series A in 2020
Cleverciti, founded in 2012 by Thomas Hohenacker, specializes in smart parking technologies aimed at optimizing outdoor parking operations. The company provides an intelligent, easy-to-deploy solution that enhances awareness, reduces traffic congestion and environmental impact, and simplifies parking management. As a leader in the smart parking sector, Cleverciti uniquely integrates intelligent parking detection with driver communication on a single platform. This allows organizations to capture and analyze data across various divisions, including operations and customer service. With a global presence that includes offices in Munich, Germany, and Chicago, Cleverciti serves a diverse range of sectors, such as retail, healthcare, and transportation. Its IoT-enabled solutions guide drivers to the nearest available parking space, ultimately improving the parking experience while helping organizations increase revenue and reduce vehicle emissions.

Kraftwerk Group

Convertible Note in 2020
Kraftwerk Group is a German renewable energy company founded in 2016, specializing in the development of advanced fuel cells that convert various fuels—such as natural gas, liquified gas, gasoline, and kerosene—into electricity. These fuel cells are designed for a diverse array of applications, including transportation solutions like e-bikes, passenger vehicles, light commercial vehicles, motorhome RVs, and medium-duty trucks. Additionally, Kraftwerk's technology supports stationary and portable systems, making it suitable for small and mid-size applications, emergency power, waste-to-energy projects, and IoT charging solutions. The company is also known for manufacturing nanocoated full metallic tubes, which are integral to building compact and efficient fuel cells for mobile use.

CureVac

Venture Round in 2020
CureVac is a clinical-stage biopharmaceutical company based in Germany, established in 2000, that specializes in developing vaccines and therapies utilizing messenger ribonucleic acid (mRNA). The company focuses on both prophylactic and therapeutic applications of mRNA, enabling the human body to produce proteins that combat various diseases. CureVac's innovative pipeline includes mRNA-based cancer immunotherapies, such as CV9104, which is in Phase IIb development for prostate cancer, as well as RNActive vaccines against infectious diseases and RNArt molecular therapies designed to stimulate the production of therapeutic proteins. Additionally, the company has collaborated with GSK to advance second-generation vaccines for seasonal influenza and COVID-19, alongside an avian influenza vaccine, while also exploring mRNA therapies for oncology and other conditions affecting the liver and eyes.

Adidas

Post in 2020
Adidas, established in 1949, is a global leader in the sporting goods industry, renowned for its innovative athletic and casual footwear, apparel, and accessories. Headquartered in Herzogenaurach, Germany, the company designs, manufactures, and markets products under its iconic three-stripe brand. Adidas caters to a broad range of consumers, from professional athletes to casual wear enthusiasts, with a focus on performance, style, and sustainability. The brand's diverse product portfolio, spanning categories like football, running, training, basketball, and originals, allows it to address multiple consumer needs and market opportunities. Adidas sells its products through a global network of owned retail stores, franchise stores, wholesale partners, and e-commerce platforms, reaching over 160 countries.

GNA Biosolutions

Series C in 2019
GNA Biosolutions is a molecular technology company located in Martinsried, Germany, specializing in the development of innovative molecular diagnostic devices for detecting and analyzing DNA. The company utilizes its proprietary Pulse Controlled Amplification technology to enhance nucleic acid amplification and detection, featuring rapid heating and cooling rates. This advancement allows laboratories to efficiently diagnose and amplify human pathogens and DNA, simplifying the molecular testing process. GNA Biosolutions aims to make the power of molecular testing accessible to a broader audience, facilitating both laboratory and on-site applications, as well as Point of Care solutions.

OMEICOS Therapeutics

Series C in 2018
OMEICOS Therapeutics GmbH is a biotechnology company based in Berlin, Germany, founded in 2013. The company focuses on developing innovative small molecule therapeutics aimed at preventing and treating cardiovascular diseases, as well as addressing inflammatory and ophthalmic conditions. OMEICOS has pioneered a novel therapeutic approach that leverages natural metabolites of omega-3 fatty acids, which exhibit a strong anti-arrhythmic effect. Its unique substances activate an endogenous cardio-protective signaling pathway, distinguishing them from traditional anti-arrhythmic drugs by not only stabilizing heart rhythm but also potentially providing curative effects by preventing electrical and structural remodeling of the heart. This technology allows for the development of metabolically robust synthetic analogs of Epoxyeicosanoids, enabling safer treatment options for cardiovascular ailments.

Veact

Series B in 2018
VEACT GmbH is a software company based in Munich, Germany, founded in 2010, specializing in after-sales marketing solutions for the automotive industry. It offers a platform that digitizes marketing processes, utilizing self-learning technology and extensive automotive expertise. By integrating various data sources such as invoices, service histories, satisfaction surveys, and campaign data, VEACT creates comprehensive customer profiles. This enables automotive dealerships and manufacturers to enhance their marketing and sales efficiency through predictive customer intelligence. The company's services aim to lower operational costs, improve customer loyalty, and ultimately drive revenue growth for its clients.

Implandata Ophthalmic Products

Series C in 2018
Implandata Ophthalmic Products GmbH is a medical device company based in Hanover, Germany, that specializes in innovative solutions for glaucoma management and treatment. Founded in 2010, the company focuses on advancing care for glaucoma patients by developing disruptive technologies. Its flagship product, Eyemate, is an implantable micro sensor designed for the continuous telemetric measurement of intraocular pressure. This biocompatible device can be permanently implanted in the patient's eye without affecting vision or overall well-being, allowing for improved monitoring and management of glaucoma. Through this technology, Implandata aims to enhance the quality of care for patients, families, and caregivers, addressing an important and underserved area in glaucoma therapy.

Acousia Therapeutics

Series B in 2018
Acousia Therapeutics GmbH is a biotechnology company based in Tübingen, Germany, focused on developing innovative treatments for hearing loss. Established in 2012, the company specializes in identifying small molecules that can be applied locally to protect or restore hearing function. Acousia's approach centers on stimulating the regeneration of sensory hair cells in the inner ear, which are crucial for hearing. This regenerative capability is achieved by leveraging supporting cells that can replace lost hair cells. The company's therapeutic candidates aim to address hearing loss caused by various factors, such as noise exposure, ototoxic medication, and sudden deafness, and also hold potential for treating age-related hearing decline.

Hemovent

Series A in 2017
Hemovent is a medical technology company based in Aachen, Germany, focused on developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Founded by Christof Lenz and Oliver Marseille, the company aims to create an innovative device that supports or replaces heart and lung functions during cardiac or respiratory failure. Hemovent's device is designed to provide respiratory support for patients with severely damaged lungs and serves as a temporary life support system, taking over heart function in cases of acute heart failure. This technology enables hospitals to stabilize patients and address underlying health issues effectively, while also allowing for increased patient mobility during treatment.

BigRep

Series B in 2017
BigRep, established in 2014, is a global leader in large-format Fused Filament Fabrication (FFF) 3D printing. Headquartered in Berlin with offices in Boston and Singapore, the company specializes in developing easy-to-use additive manufacturing solutions. BigRep's German-engineered 3D printers enable businesses, from start-ups to Fortune 100 companies, to accelerate innovation and rethink manufacturing by efficiently transitioning from prototyping to production. Through strategic partnerships and collaborations, BigRep offers complete additive manufacturing solutions, including industrial 3D printers, software, and advanced materials. Notably, BigRep's printers can print objects at a 1:1 scale, transforming the manufacturing process and helping companies bring products to market faster.

OMEICOS Therapeutics

Series B in 2017
OMEICOS Therapeutics GmbH is a biotechnology company based in Berlin, Germany, founded in 2013. The company focuses on developing innovative small molecule therapeutics aimed at preventing and treating cardiovascular diseases, as well as addressing inflammatory and ophthalmic conditions. OMEICOS has pioneered a novel therapeutic approach that leverages natural metabolites of omega-3 fatty acids, which exhibit a strong anti-arrhythmic effect. Its unique substances activate an endogenous cardio-protective signaling pathway, distinguishing them from traditional anti-arrhythmic drugs by not only stabilizing heart rhythm but also potentially providing curative effects by preventing electrical and structural remodeling of the heart. This technology allows for the development of metabolically robust synthetic analogs of Epoxyeicosanoids, enabling safer treatment options for cardiovascular ailments.

Amcure

Series B in 2016
Amcure GmbH is a clinical-stage biopharmaceutical company based in Eggenstein-Leopoldshafen, Germany, focused on the research and development of peptide-based compounds aimed at treating highly metastatic forms of squamous cancer. Founded in 2011 as a spin-off from the Karlsruhe Institute of Technology, Amcure leverages its expertise in CD44 target biology to develop innovative therapeutic approaches. Its lead compound, AM001, is a first-in-class CD44v6 inhibitor that disrupts key receptor tyrosine kinase pathways, including the VEGF/VEGF-R and HGF/c-Met pathways. This advancement is particularly relevant for treating various cancers such as pancreatic, head and neck, gastric, colorectal, breast, and lung cancers. Amcure's commitment to addressing the challenges of metastatic cancer is underscored by its clinical development efforts, which began in late 2016.

Acousia Therapeutics

Series A in 2016
Acousia Therapeutics GmbH is a biotechnology company based in Tübingen, Germany, focused on developing innovative treatments for hearing loss. Established in 2012, the company specializes in identifying small molecules that can be applied locally to protect or restore hearing function. Acousia's approach centers on stimulating the regeneration of sensory hair cells in the inner ear, which are crucial for hearing. This regenerative capability is achieved by leveraging supporting cells that can replace lost hair cells. The company's therapeutic candidates aim to address hearing loss caused by various factors, such as noise exposure, ototoxic medication, and sudden deafness, and also hold potential for treating age-related hearing decline.

Arzneimittelwerk Warngau

Series C in 2016
Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

CryoTherapeutics

Series B in 2016
CryoTherapeutics GmbH, founded in 2009 and based in Cologne, Germany, specializes in the development of a proprietary cryotherapy system aimed at treating coronary artery disease, a major cause of heart attacks. The company focuses on demonstrating the clinical benefits and ensuring the safety and efficacy of cryoenergy in the cardiovascular system. Its novel catheter system utilizes cryo energy to treat and prevent heart attacks, offering a promising approach to addressing the challenges posed by diseased coronary arteries. Through its early-stage commercialization efforts, CryoTherapeutics aims to enhance treatment options for heart surgeons and improve patient outcomes in cardiovascular health.

fromAtoB

Series A in 2016
fromAtoB GmbH is a travel search engine based in Munich, Germany, that facilitates multimodal journey planning for users across Europe, North America, and internationally. Founded in 2008, the company integrates various transportation options, including trains, flights, ride shares, long-distance buses, taxis, rental cars, and public transport. Its platform allows users to compare prices, access deals, and book trips with multiple mobility providers efficiently. With a focus on enhancing the travel experience, fromAtoB's journey planner collaborates with a wide range of travel partners to provide comprehensive information and secure booking options for users seeking to optimize their travel plans.

Readfy

Seed Round in 2016
Readfy GmbH is a digital reading platform based in Düsseldorf, Germany, founded in 2013. It enables users to read e-books on tablets and smartphones, offering a wide range of genres including classical literature, crime, science fiction, romance, non-fiction, travel guides, biographies, and more, in multiple languages such as English and Spanish. Readfy positions itself as a social reading experience, allowing users unlimited access to content in a unique and interactive manner. The company's innovative approach aims to transform the publishing industry by providing a comprehensive and engaging platform for readers.

Hemovent

Series A in 2016
Hemovent is a medical technology company based in Aachen, Germany, focused on developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Founded by Christof Lenz and Oliver Marseille, the company aims to create an innovative device that supports or replaces heart and lung functions during cardiac or respiratory failure. Hemovent's device is designed to provide respiratory support for patients with severely damaged lungs and serves as a temporary life support system, taking over heart function in cases of acute heart failure. This technology enables hospitals to stabilize patients and address underlying health issues effectively, while also allowing for increased patient mobility during treatment.

Trinckle

Seed Round in 2015
Trinckle is a Berlin-based company specializing in software solutions for additive manufacturing. Its primary product, Paramate, automates design processes and offers a platform for advanced product configuration. This technology allows for customer-specific adaptations across a range of applications, including personalized prostheses, optimized industrial components, and unique lifestyle products. By utilizing a cloud-based platform, Trinckle streamlines the design workflow and automates complex tasks, enabling businesses to efficiently transform digital designs into tangible items through 3D printing. The company's focus is on making the 3D printing process more accessible and cost-effective for various industries.

Cleverciti

Seed Round in 2015
Cleverciti, founded in 2012 by Thomas Hohenacker, specializes in smart parking technologies aimed at optimizing outdoor parking operations. The company provides an intelligent, easy-to-deploy solution that enhances awareness, reduces traffic congestion and environmental impact, and simplifies parking management. As a leader in the smart parking sector, Cleverciti uniquely integrates intelligent parking detection with driver communication on a single platform. This allows organizations to capture and analyze data across various divisions, including operations and customer service. With a global presence that includes offices in Munich, Germany, and Chicago, Cleverciti serves a diverse range of sectors, such as retail, healthcare, and transportation. Its IoT-enabled solutions guide drivers to the nearest available parking space, ultimately improving the parking experience while helping organizations increase revenue and reduce vehicle emissions.

BigRep

Series A in 2015
BigRep, established in 2014, is a global leader in large-format Fused Filament Fabrication (FFF) 3D printing. Headquartered in Berlin with offices in Boston and Singapore, the company specializes in developing easy-to-use additive manufacturing solutions. BigRep's German-engineered 3D printers enable businesses, from start-ups to Fortune 100 companies, to accelerate innovation and rethink manufacturing by efficiently transitioning from prototyping to production. Through strategic partnerships and collaborations, BigRep offers complete additive manufacturing solutions, including industrial 3D printers, software, and advanced materials. Notably, BigRep's printers can print objects at a 1:1 scale, transforming the manufacturing process and helping companies bring products to market faster.

Aquila Biolabs

Seed Round in 2015
Aquila Biolabs GmbH is a German technology company established in 2014 and headquartered in Baesweiler, specializing in the development of innovative laboratory devices for bioprocess analysis. The company focuses on creating smart sensors and data analytics software to enhance bioprocessing workflows, particularly in the fields of biotechnology, chemistry, and pharmaceuticals. Its key products include the Cell Growth Quantifier, which allows for real-time, non-invasive monitoring of cell biomass in shake flasks, and the Liquid Injection System, which facilitates automated analysis and optimization of fermentation processes. By providing research scientists with actionable insights during cultivation, Aquila Biolabs aims to simplify and accelerate the development of therapeutics.

Sicoya

Series A in 2015
Sicoya GmbH, founded in January 2015 as a spin-off from TU Berlin, specializes in the design, packaging, and sale of application-specific photonic integrated circuits (ASPICs). Based in Berlin, Germany, the company focuses on silicon photonics technology, leveraging research and development efforts that began in 2007. Sicoya entered the data center interconnect market in 2017 with the introduction of a 100G transceiver chip that combines integrated electronics and optics on a single chip. This innovation aims to enhance internet connectivity through power-efficient and scalable optical transceiver solutions. The company has received initial purchase orders for qualification units and is preparing customer samples for major data center operators, with the vision of enabling high-speed silicon photonics interconnects that facilitate new internet services.

Veact

Series A in 2015
VEACT GmbH is a software company based in Munich, Germany, founded in 2010, specializing in after-sales marketing solutions for the automotive industry. It offers a platform that digitizes marketing processes, utilizing self-learning technology and extensive automotive expertise. By integrating various data sources such as invoices, service histories, satisfaction surveys, and campaign data, VEACT creates comprehensive customer profiles. This enables automotive dealerships and manufacturers to enhance their marketing and sales efficiency through predictive customer intelligence. The company's services aim to lower operational costs, improve customer loyalty, and ultimately drive revenue growth for its clients.

Datapine

Series A in 2015
Datapine GmbH is a Berlin-based company specializing in data visualization and business intelligence (BI) solutions. Founded in 2012, it offers a Software-as-a-Service (SaaS) platform designed to simplify the complex process of data analytics for users of all technical backgrounds. The platform provides a range of tools, including self-service BI, decision support, visual analytics, and reporting capabilities that enable businesses to explore, monitor, and share data effectively. Datapine's solutions are utilized across various sectors, including energy, financial services, healthcare, and retail, helping teams in finance, marketing, and operations to make informed decisions by uncovering insights and trends in their data. The company also offers consulting services and ETL-as-a-Service to further support its clients' analytic needs. As a subsidiary of RIB Software SE, Datapine aims to lead innovation in the BI market, particularly for small and medium-sized enterprises.

Minodes

Seed Round in 2015
Minodes GmbH, founded in 2013 and based in Berlin, Germany, provides a platform designed to enhance the performance of offline retail stores. The Minodes platform enables retailers to gather insights and metrics related to factors influencing customer behavior and in-store revenues. It offers tools for optimizing operations, store design, and marketing strategies tailored to different customer segments, from first-time visitors to loyal patrons. Additionally, the platform supports location-based mobile marketing campaigns to enrich the in-store experience. By utilizing Minodes, retailers can measure and refine their marketing campaigns and shop window designs, ultimately driving store traffic and improving consumer engagement. As of May 2017, Minodes operates as a subsidiary of Telefónica Germany NEXT GmbH.

OMEICOS Therapeutics

Series A in 2015
OMEICOS Therapeutics GmbH is a biotechnology company based in Berlin, Germany, founded in 2013. The company focuses on developing innovative small molecule therapeutics aimed at preventing and treating cardiovascular diseases, as well as addressing inflammatory and ophthalmic conditions. OMEICOS has pioneered a novel therapeutic approach that leverages natural metabolites of omega-3 fatty acids, which exhibit a strong anti-arrhythmic effect. Its unique substances activate an endogenous cardio-protective signaling pathway, distinguishing them from traditional anti-arrhythmic drugs by not only stabilizing heart rhythm but also potentially providing curative effects by preventing electrical and structural remodeling of the heart. This technology allows for the development of metabolically robust synthetic analogs of Epoxyeicosanoids, enabling safer treatment options for cardiovascular ailments.

GNA Biosolutions

Series B in 2015
GNA Biosolutions is a molecular technology company located in Martinsried, Germany, specializing in the development of innovative molecular diagnostic devices for detecting and analyzing DNA. The company utilizes its proprietary Pulse Controlled Amplification technology to enhance nucleic acid amplification and detection, featuring rapid heating and cooling rates. This advancement allows laboratories to efficiently diagnose and amplify human pathogens and DNA, simplifying the molecular testing process. GNA Biosolutions aims to make the power of molecular testing accessible to a broader audience, facilitating both laboratory and on-site applications, as well as Point of Care solutions.

WeSustain

Series B in 2014
WeSustain is a company that specializes in developing web-based software for enterprise sustainability management. Founded in 2010 and based in Buxtehude, Germany, WeSustain's software assists organizations in measuring, improving, and communicating their sustainability performance. The platform offers a comprehensive management support system that enables clients to implement and manage sustainability initiatives effectively, while also addressing sustainability risks. In addition to its core software, WeSustain provides services such as organizational models, reporting standards, enterprise compliance, stakeholder surveys, and customized workflows. This holistic approach allows companies to enhance their sustainability practices, improve operational efficiency, and promote profitability.

Electrochaea

Series A in 2014
Electrochaea GmbH is a German company specializing in the development and commercialization of innovative power-to-gas energy storage technology. Founded in 2010 and headquartered in Planegg, Germany, with additional facilities in Denmark and California, Electrochaea's proprietary biocatalytic process converts low-cost electricity and carbon dioxide into pipeline-grade renewable methane, the primary component of natural gas. This technology enables the efficient storage of renewable energy generated from sources like wind and solar, facilitating grid balancing and carbon recycling. By converting stranded electricity into renewable gas, Electrochaea provides a solution for utility-scale energy storage and supports the decarbonization of transportation and natural gas grids. The company aims to enhance existing infrastructure for energy transmission and contribute to a more sustainable energy landscape.

Implandata Ophthalmic Products

Series B in 2014
Implandata Ophthalmic Products GmbH is a medical device company based in Hanover, Germany, that specializes in innovative solutions for glaucoma management and treatment. Founded in 2010, the company focuses on advancing care for glaucoma patients by developing disruptive technologies. Its flagship product, Eyemate, is an implantable micro sensor designed for the continuous telemetric measurement of intraocular pressure. This biocompatible device can be permanently implanted in the patient's eye without affecting vision or overall well-being, allowing for improved monitoring and management of glaucoma. Through this technology, Implandata aims to enhance the quality of care for patients, families, and caregivers, addressing an important and underserved area in glaucoma therapy.

AYOXXA

Series B in 2014
AYOXXA Biosystems GmbH is a life science tools company based in Cologne, Germany, with additional offices in Singapore and Boston, Massachusetts. Founded in 2010, AYOXXA specializes in developing a proprietary technology platform for multiplexed protein analysis. This platform, which utilizes In-situ Encoded Bead-based Arrays, enables users to simultaneously measure multiple protein markers associated with various health conditions, including cancer, allergies, cardiovascular diseases, and infectious diseases. AYOXXA's innovative biochips merge biological analysis with information technology, expanding the potential applications in biomedical research. The company also offers biomarker kits to facilitate the identification and quantification of proteins and other biomolecular analytes.

Streetspotr

Seed Round in 2014
Streetspotr GmbH is a retail intelligence company based in Nürnberg, Germany, that offers a smartphone application designed to connect businesses with a mobile workforce across Europe. The Streetspotr app allows businesses to post tasks, which are then fulfilled by a community of mobile workers located near the task site. This platform provides real-time data and insights related to products and promotions in retail environments, enabling brands and retailers to enhance the shopping experience and drive in-store sales. Streetspotr's solutions cater to various industries, including market research, consumer goods, and retail, delivering actionable intelligence to inform smarter business decisions. In November 2018, Streetspotr was acquired by POSpulse GmbH.

flinc

Venture Round in 2014
flinc AG is a German company founded in 2010, specializing in a social mobility network application that facilitates real-time ridesharing by matching drivers and passengers. Based in Ludwigshafen, flinc's innovative platform integrates navigation technology, enabling seamless communication and route coordination without the need for phone calls or text messages. The application allows users to share rides for short to medium-length journeys, offering a dynamic and automated service that can be accessed via desktop, smartphone, or navigation devices. Users can customize their ride-sharing experience by connecting with direct contacts, peer groups, or the broader network. Additionally, flinc provides solutions for companies and public transit organizations, promoting environmentally friendly commuting alternatives. By combining various transportation modes, including public transit schedules, flinc aims to enhance the commuting experience while reducing costs and stress associated with traditional travel. In 2017, flinc became a subsidiary of moovel GmbH, further solidifying its position in the mobility sector.

simplesurance

Venture Round in 2013
Simplesurance GmbH, founded in 2012 and headquartered in Berlin, Germany, specializes in developing cross-selling software solutions for e-commerce platforms. The company's technology integrates into the checkout processes of online shops, enabling customers to purchase both products and corresponding insurance simultaneously. This innovative approach allows e-commerce retailers to monetize customer transactions more effectively, boosting their margins and profitability. Simplesurance's offerings include a digital broker service that allows users to manage their insurance conveniently via smartphones, ensuring a fully paperless experience. With over 2,000 partners, including prominent e-commerce platforms and electronic manufacturers, Simplesurance is recognized for its flexible and efficient solutions that enhance the intersection of traditional insurance and digital commerce. The company also maintains an additional office in Tokyo, Japan.

Capical

Series A in 2013
Capical GmbH is a German company specializing in the development and marketing of innovative electrocardiography (ECG) devices that utilize capacitive electrode technology for contact-free patient monitoring. Founded in 2010 and based in Braunschweig, Capical has established itself as a leader in this field, focusing on high-resolution ECG measurements that allow healthcare professionals to assess heart activity without direct skin contact. The company’s technology finds applications beyond healthcare, including in automotive and furniture sectors, where it can monitor driver states and physiological parameters in various settings. Capical is committed to research and development, continuously enhancing its product offerings, and has received multiple awards for its achievements in technology transfer and innovation. The company aims to enhance the quality of life for individuals, especially the elderly or those with health challenges, while also improving safety and comfort in automated driving environments.

miacosa

Venture Round in 2013
miacosa.de is operated by the Endorsed Goods GmbH. miacosa.de is a social shopping concept from Germany based in Cologne. Social Shopping the miacosa way means that members select their personal shopping team of experts and celebrities that present products they love on miacosa.de Miacosa is for members only. The free service starts with products from the fields of Health Style, Home & Living, Kitchen and fashion accessories.

Sirion Biotech

Venture Round in 2013
Sirion Biotech is a prominent company specializing in viral vector technology, which is essential for innovative therapeutics and gene modification in mammalian cells. Founded in 2007, the company has established itself as a leader in providing various viral vectors, including adenovirus, adeno-associated virus (AAV), and lentivirus, available in rapid turnaround times. Sirion's technology enables researchers to deliver genetic material into cells effectively, facilitating advancements in gene therapy and the development of new drug compounds. The company offers a comprehensive range of services, from particle production to virus-driven cell modeling, meeting the demands for preclinical, clinical, and animal testing. With a global presence in Munich, Tokyo, New Hampshire, and Tel Aviv, Sirion has successfully completed over 500 projects for both academic and industrial clients, demonstrating an annual growth rate of 70%. The business model includes flexible commercial arrangements, such as fee-for-service and licensing agreements, as the company continues to seek opportunities for further growth and technological advancement.

Orpheus GmbH

Series A in 2013
Orpheus GmbH, founded in 2005 by Dr. Joerg Dittrich and Michael Lauer, specializes in developing software products for spend and procurement performance management. Based in Nuremberg, Germany, with an additional office in Mainz, the company offers a range of solutions, including SpendControl, which facilitates procurement controlling and spend analysis, and InitiativeTracker, designed for managing sourcing initiatives. Orpheus also provides data management tools such as a data consolidation solution and DeltaClass for automatic classification of invoices and orders. To protect sensitive information, the company offers the DataMaskingSuite. Additionally, Orpheus develops custom business intelligence solutions and provides consulting services related to spend management and data management. Their client base includes small, medium, and large enterprises in Germany and internationally, including notable DAX and MDAX companies.

ZooRoyal

Venture Round in 2013
ZooRoyal is an online platform that offers accessories and supplies for pet dogs, cats, reptiles, horses, fish, and more. Its operations are based in Würselen, Germany.

clickworker

Venture Round in 2012
Clickworker GmbH is a leading provider of crowdsourcing solutions based in Essen, Germany, specializing in internet-based services both domestically and internationally. Founded in 2005, the company has built a large network of over 6 million freelancers, known as Clickworkers, across Europe, America, and Asia. Clickworker offers a wide range of services, including web research, text creation, categorization, surveys, and mobile crowdsourcing, all delivered in 18 languages and over 30 target markets. The company efficiently breaks down projects into micro tasks that are completed by qualified Clickworkers, ensuring high-quality results through a quality assurance process. Additionally, Clickworker provides a self-service marketplace for smaller tasks, enabling clients to access standardized solutions for text creation, surveys, and sentiment analysis. Its cloud platform enhances data management for e-commerce, offering services such as search engine optimization and data authentication, which help clients accelerate project execution and achieve cost savings. The company was previously known as humanGrid GmbH until its name change in 2013.

Regiohelden

Series A in 2012
Regiohelden GmbH, founded in 2010 and based in Stuttgart, Germany, specializes in providing online marketing services tailored for small businesses, entrepreneurs, and regional companies. The company focuses on search engine optimization and marketing, helping local advertisers reach their online audience, convert prospects into clients, and measure campaign results effectively. Regiohelden enables its clients to leverage the internet for business growth, supporting them with targeted digital marketing strategies.

avandeo

Venture Round in 2012
avandeo, a Munich, Germany- and Shanghai, China-based startup that operates an online destination for designer furniture and home accessories.

Zalando

Debt Financing in 2012
Zalando is a leading European online fashion platform based in Berlin, founded in 2008. It offers a wide assortment of clothing, footwear, accessories, and beauty products, featuring over 7,000 brands and catering to nearly 50 million active customers across 25 markets. The company has established a significant presence in the DACH region, which includes Germany, Austria, and Switzerland, accounting for a substantial portion of its revenue. Zalando aims to provide an exceptional online shopping experience by continuously enhancing its technology, logistics, and marketing strategies. Its logistics network includes 13 fulfillment centers strategically located to efficiently serve local customer needs. As Europe's largest pure-play online fashion retailer, Zalando strives to be the go-to destination for fashion inspiration, innovation, and interaction.

Orpheus GmbH

Seed Round in 2012
Orpheus GmbH, founded in 2005 by Dr. Joerg Dittrich and Michael Lauer, specializes in developing software products for spend and procurement performance management. Based in Nuremberg, Germany, with an additional office in Mainz, the company offers a range of solutions, including SpendControl, which facilitates procurement controlling and spend analysis, and InitiativeTracker, designed for managing sourcing initiatives. Orpheus also provides data management tools such as a data consolidation solution and DeltaClass for automatic classification of invoices and orders. To protect sensitive information, the company offers the DataMaskingSuite. Additionally, Orpheus develops custom business intelligence solutions and provides consulting services related to spend management and data management. Their client base includes small, medium, and large enterprises in Germany and internationally, including notable DAX and MDAX companies.

evidanza

Series C in 2012
Evidanza AG is a software provider specializing in business intelligence solutions, focusing on transforming complex data into actionable insights. Founded in 2001 and headquartered in Regensburg, Germany, the company develops software based on Microsoft technologies that supports various business functions, including reporting, planning, OLAP analysis, risk management, and compliance with IFRS and US GAAP standards. Evidanza's software aims to digitize and optimize commercial operations and organizational processes such as accounting, cost accounting, customer relationship management, and corporate planning. By enhancing data management capabilities, the company seeks to improve clients' cash flow, cost structures, and overall business models.

Subitec

Series B in 2012
Subitec GmbH, founded in 2000 in Stuttgart, Germany, specializes in the manufacture of microalgae biotechnology cultivation equipment and turn-key production systems. The company offers a range of products, including Flat Panel Airlift Photobioreactors with various cultivation volumes, along with essential components such as lighting systems, media feeds, temperature control, and harvesting solutions. Subitec's systems encompass engineering and construction for outdoor and indoor applications, as well as compact and hybrid systems, catering to diverse markets including nutraceuticals, food and feed, aquaculture, cosmetics, and energy. Originating as a spin-off from the Fraunhofer Institute for Interfacial and Biotechnology, Subitec focuses on enabling clients to produce sustainable bio-products from high-quality microalgae.

Algiax Pharmaceuticals

Series A in 2012
Algiax Pharmaceuticals GmbH is a biotechnology company based in Erkrath, Germany, founded in April 2011. The company specializes in the discovery and development of innovative therapies targeting nervous system diseases, particularly focusing on neuropathic pain and spinal cord injuries. Algiax Pharmaceuticals is engaged in developing molecules to inhibit the enzyme dehydroorotate dehydrogenase, aiming to address critical needs in the treatment of central nervous system disorders. With a commitment to addressing chronic pain and other nervous system dysfunctions, the company is positioned to meet significant medical needs in this area. Algiax Pharmaceuticals has secured financial backing, raising 4.3 million Euros in Series A financing from a mix of private and state-supported investors, which supports its ongoing research and development efforts.

Micropelt

Venture Round in 2012
Micropelt is a startup that evolved from a collaboration between Infineon Technologies AG and the Fraunhofer Institute for Physical Measurement Techniques in Freiburg, Germany. The company specializes in the development of thin film thermoelectric components, leveraging semiconductor manufacturing processes to create energy harvesting systems. These systems are designed to power micro-actuators and sensors, focusing specifically on thermoelectric cooling chips and thermogenerators. Micropelt's products are utilized in various applications, including chip spot cooling, biomedical devices, heating, ventilation, air-conditioning systems, and optical sensors. Their innovative technology aims to enhance temperature management in individual rooms while contributing to CO2 reduction and improving overall user comfort.

simplesurance

Seed Round in 2012
Simplesurance GmbH, founded in 2012 and headquartered in Berlin, Germany, specializes in developing cross-selling software solutions for e-commerce platforms. The company's technology integrates into the checkout processes of online shops, enabling customers to purchase both products and corresponding insurance simultaneously. This innovative approach allows e-commerce retailers to monetize customer transactions more effectively, boosting their margins and profitability. Simplesurance's offerings include a digital broker service that allows users to manage their insurance conveniently via smartphones, ensuring a fully paperless experience. With over 2,000 partners, including prominent e-commerce platforms and electronic manufacturers, Simplesurance is recognized for its flexible and efficient solutions that enhance the intersection of traditional insurance and digital commerce. The company also maintains an additional office in Tokyo, Japan.

numares

Venture Round in 2012
numares AG is a German company that specializes in developing and marketing software-based test systems for clinical diagnostics and life science research. Founded in 2004 and headquartered in Regensburg, the company employs nuclear magnetic resonance (NMR) spectroscopy to create diagnostic tests that evaluate metabolomic networks. Its AXINON in vitro diagnostic (IVD) system produces a numeric spectrum that provides valuable insights into patients' disease statuses, assisting physicians in their evaluations. Utilizing magnetic group signaling (MGS) technology, numares focuses on diagnostics in areas such as cardiovascular diseases, nephrology, oncology, and neurology. The company is recognized as a leader in commercial NMR analytics in Europe, offering a comprehensive range of NMR-analytic services that are fast, cost-efficient, and reliable, enabling doctors to interpret complex metabolic patterns from blood and urine samples effectively.

Intelligent Apps

Series B in 2012
Intelligent Apps, founded by Niclaus Mewes and Sven Kuelper in 2009, is recognized for developing mytaxi, the first taxi app that creates a direct connection between passengers and drivers. This innovative platform has rapidly expanded, boasting over 7 million downloads and connecting 35,000 taxis across more than 40 cities worldwide, including major locations like Washington, Madrid, and Zurich. mytaxi enhances the taxi service experience by allowing drivers to operate as independent contractors, fostering a competitive environment that encourages high-quality service and customer ratings. The app provides transparency in the ordering process, enabling passengers to track their taxi's arrival and view driver details. Drivers benefit from a favorable cost model, paying only for completed trips. Intelligent Apps aims to advance urban mobility and solidify its leadership position in the industry by continuously improving its services and expanding its reach. The company also provides app development services for Daimler Mobility Services, further enhancing its capabilities in the mobility sector.

Humedics

Series A in 2011
Humedics GmbH, founded in 2009 and based in Berlin, Germany, specializes in developing innovative solutions for liver function assessment. The company's flagship product, the LiMAx test, is a breath analysis device that enables real-time measurement of liver function in patients with liver failure. This easy-to-use bedside system includes a medical device, breath masks, and a diagnostic drug, allowing clinicians to accurately quantify liver function capacity. The LiMAx test is utilized in various clinical applications, such as evaluating liver function prior to and following liver transplantation, planning for living donor liver resection, and assessing conditions like liver cirrhosis. With its technology already benefiting thousands of patients, Humedics is actively expanding its global operations to enhance patient outcomes through tailored medical treatment.

numares

Venture Round in 2011
numares AG is a German company that specializes in developing and marketing software-based test systems for clinical diagnostics and life science research. Founded in 2004 and headquartered in Regensburg, the company employs nuclear magnetic resonance (NMR) spectroscopy to create diagnostic tests that evaluate metabolomic networks. Its AXINON in vitro diagnostic (IVD) system produces a numeric spectrum that provides valuable insights into patients' disease statuses, assisting physicians in their evaluations. Utilizing magnetic group signaling (MGS) technology, numares focuses on diagnostics in areas such as cardiovascular diseases, nephrology, oncology, and neurology. The company is recognized as a leader in commercial NMR analytics in Europe, offering a comprehensive range of NMR-analytic services that are fast, cost-efficient, and reliable, enabling doctors to interpret complex metabolic patterns from blood and urine samples effectively.

Sividon Diagnostics

Private Equity Round in 2011
Sividon Diagnostics GmbH is a specialized diagnostics company based in Cologne, Germany, focused on the development of treatment-related diagnostic tests, particularly in the field of oncology. Founded in 2011, Sividon emerged from a management buyout of Siemens Healthcare Diagnostics, with a mission to enhance the quality of companion diagnostics. The company’s product portfolio includes the ImmunoPredict biomarker test and the EndoPredict RNA expression test, which evaluates the aggressiveness of breast cancer by analyzing 12 genes at a molecular level. Sividon is driven by a team of experienced scientists and managers dedicated to improving individualized, evidence-based diagnosis in cancer treatment, supported by a network of international experts and extensive rights to technology developed since 2004. As a subsidiary of Myriad Services GmbH, Sividon aims to advance treatment decisions in oncology, particularly for breast cancer.

Pay by Shopping (deal united)

Series B in 2011
Pay by Shopping is an innovative tool that can be used to reach new customers, increase website traffic, and to raise conversion rates. Available on browser games, via Mobile, and as a Facebook-App, Pay by Shopping enables users to earn virtual currency and items, such as rebates, from a Publisher by shopping at an Advertiser. It drives incremental revenue for Publishers while at the same time serving as a performance marketing tool for online Advertisers. Advertisers gain new customers and see increased sales. Current partnerships include Facebook, OTTO, Zalando, Ubisoft, and Bigpoint. Pay by Shopping is a product of deal united GmbH. The firm is based in Munich with offices in Paris and San Francisco.

Sirion Biotech

Venture Round in 2011
Sirion Biotech is a prominent company specializing in viral vector technology, which is essential for innovative therapeutics and gene modification in mammalian cells. Founded in 2007, the company has established itself as a leader in providing various viral vectors, including adenovirus, adeno-associated virus (AAV), and lentivirus, available in rapid turnaround times. Sirion's technology enables researchers to deliver genetic material into cells effectively, facilitating advancements in gene therapy and the development of new drug compounds. The company offers a comprehensive range of services, from particle production to virus-driven cell modeling, meeting the demands for preclinical, clinical, and animal testing. With a global presence in Munich, Tokyo, New Hampshire, and Tel Aviv, Sirion has successfully completed over 500 projects for both academic and industrial clients, demonstrating an annual growth rate of 70%. The business model includes flexible commercial arrangements, such as fee-for-service and licensing agreements, as the company continues to seek opportunities for further growth and technological advancement.

Vimecon

Venture Round in 2011
Vimecon GmbH, founded in 2005 and headquartered in Herzogenrath, Germany, specializes in the development and production of laser catheters aimed at treating heart diseases, particularly atrial fibrillation. The company also manufactures a range of products for the medical technology and biotechnology sectors, including microscopically small catheters and micro materials handling techniques that facilitate precise measurement and dosage. In addition to its product offerings, Vimecon provides advisory services to various clients in both academic and industrial research and development. Through its innovative solutions, the company aims to enhance healthcare outcomes in the treatment of cardiovascular diseases and cardiac arrhythmias.

CYNORA

Series A in 2011
CYNORA GmbH is a Bruchsal, Germany-based company specializing in the development and manufacturing of organic electronics, particularly for organic light-emitting diode (OLED) displays. Founded in 2008, CYNORA focuses on creating advanced materials that utilize Thermally Activated Delayed Fluorescence (TADF) technology to produce efficient blue and green emitters. These emitters are designed to enhance the power efficiency and color contrast of OLED devices, addressing the growing demand for thinner, flexible screens with improved performance and lower energy consumption. By providing iridium-free, purely organic emitter systems tailored for modern vacuum processing, CYNORA aims to deliver significant value to OLED producers and meet the evolving expectations within the display market.

OctreoPharm Sciences

Venture Round in 2011
OctreoPharm Sciences GmbH is a Berlin-based biopharmaceutical company specializing in the development of radiopharmaceuticals for the diagnosis and treatment of neuroendocrine tumors. Founded in 2010, the company is engaged in clinical development of theranostic antagonistic peptides specifically designed for tumor diagnosis and therapeutic control. Its key products include OPS201, which targets tumor cell-selective internal peptide receptor radionuclide therapy using 90Y or 177Lu, and OPS202, a novel 68 gallium-labeled somatostatin receptor antagonist intended for use in positron emission tomography. As of mid-2015, OctreoPharm Sciences operates as a subsidiary of Ipsen S.A.

clickworker

Series B in 2011
Clickworker GmbH is a leading provider of crowdsourcing solutions based in Essen, Germany, specializing in internet-based services both domestically and internationally. Founded in 2005, the company has built a large network of over 6 million freelancers, known as Clickworkers, across Europe, America, and Asia. Clickworker offers a wide range of services, including web research, text creation, categorization, surveys, and mobile crowdsourcing, all delivered in 18 languages and over 30 target markets. The company efficiently breaks down projects into micro tasks that are completed by qualified Clickworkers, ensuring high-quality results through a quality assurance process. Additionally, Clickworker provides a self-service marketplace for smaller tasks, enabling clients to access standardized solutions for text creation, surveys, and sentiment analysis. Its cloud platform enhances data management for e-commerce, offering services such as search engine optimization and data authentication, which help clients accelerate project execution and achieve cost savings. The company was previously known as humanGrid GmbH until its name change in 2013.

Bettermarks

Venture Round in 2011
Bettermarks GmbH, established in 2008 and headquartered in Berlin, Germany, specializes in an adaptive learning system for mathematics. It replaces traditional textbooks and exercise books, offering over 100 interactive math books for primary and secondary levels (grades 4-10, ages 10-16), covering topics like fractions, algebra, geometry, and more. The system provides more than 100,000 questions with detailed explanations, automatic marking, and result evaluation. It connects teachers, mathematicians, and software specialists to guide students through exercises systematically, offering constructive feedback and helping teachers manage diverse learning abilities in the classroom. The platform is available in German, English, and Spanish, providing a personalized learning experience that goes beyond simply indicating correct or incorrect answers, instead analyzing responses to detect errors and propose alternative solutions.

SAW Instruments

Series B in 2011
SAW Instruments is a manufacturer and distributor specializing in innovative analytical systems for the life sciences market. Its products enable label-free analysis of molecular biomolecular interactions, combining stability, ease of use, and high sensitivity. These instruments are successfully employed by prominent research institutions in Germany and Switzerland.

Fairrank

Venture Round in 2011
Fairrank GmbH is a German-based company founded in 2004, operating as a subsidiary of Euro Serve Media GmbH since 2015. It specializes in providing search engine optimization (SEO) and marketing services to small and medium-sized businesses across Germany, Austria, and Switzerland. Fairrank's offerings include assessing clients' existing web presence for improvement, enhancing visitor numbers through tailored strategies, and delivering comprehensive digital marketing solutions such as social media marketing, content marketing, web development, and usability optimization. The company serves diverse industries via a network of sales representatives, aiming to boost clients' sales and productivity through effective online marketing strategies.

Gilupi

Series C in 2011
GILUPI GmbH is a medical device company based in Potsdam, Germany, specializing in the development and production of diagnostic products aimed at the in vivo isolation of rare cells from circulating blood. The company's primary focus is on isolating tumor cells, utilizing devices that employ predetermined selectivity of antibodies bound to nano-detectors. This technology enables healthcare professionals to effectively isolate circulating tumor cells within patients' blood, facilitating more precise diagnoses and tailored therapeutic interventions. GILUPI's devices are CE certified, ensuring their compliance with safety and efficacy standards, which enhances their credibility and utility in clinical settings.

Blue Lion Mobile (QEEP)

Series B in 2010
Based in Cologne, Germany, BLUE LION mobile GmbH is a tech startup that offers new types of communication and entertainment for the mobile phone. BLUE LION Mobile produces and distributes the mobile social-networking application and multiplayer gaming platform "qeep." Founded in 2006, the team is led by Cornelius Rost, Arefin Bashar Arif and Christian R. Schulte, who teamed up to head this venture after years of experience in the industries of telecommunications and hand-held devices.

Zimory

Venture Round in 2010
Zimory GmbH, established in 2007, specializes in providing carrier-grade cloud infrastructure management software. Headquartered in Berlin with development centers in Erfurt, Germany, and Minsk, Belarus, the company simplifies and automates the creation, launch, and management of diverse cloud environments for service providers, enterprises, and cloud brokers. Zimory's software enables efficient resource allocation, facilitates cloud marketplaces, and handles settlement processes between buyers and sellers. It also offers consulting services and supports global telecommunications carriers and governments. As of September 2016, the company was in liquidation.

VIOSO

Series B in 2010
VIOSO GmbH, founded in 2007 and based in Düsseldorf, Germany, specializes in automatic digital edge-blending and geometry alignment solutions for various visual applications. The company offers a range of products, including VIOSO Player, a professional video playback software designed for custom screen surfaces like fulldome displays, and VIOSO Anyblend, an embedded warping and blending solution suitable for simulators, signage, and interactive experiences. VIOSO also provides technology for military and non-commercial simulators with its Anyblend VR & SIM product, as well as a media server solution, Wings VIOSO, for large venues and events. Additional offerings include high-resolution display solutions like VIOSO Blackbox 4K, autoalignment for video walls, and fulldome solutions for immersive content display. The company is committed to enhancing presentations and delivering innovative software solutions, leveraging expertise and experience gained since its inception.

Phenex Pharmaceuticals

Series C in 2010
Phenex Pharmaceuticals AG is a privately held drug discovery and development company based in Ludwigshafen, Germany, with additional facilities in Heidelberg. Founded in 2002, the company specializes in small-molecule drug discovery, focusing on liver diseases, intestinal diseases, and cancer. Its research includes developing retinoid-acid receptor-related orphan receptor gamma t (RORγt) inverse agonists for autoimmune diseases and farnesoid X receptor (FXR) agonists for non-alcoholic steatohepatitis. Phenex aims to identify novel molecular mechanisms and develop innovative therapeutics, having already translated two such mechanisms into proprietary small molecules.

GreenPocket

Series A in 2010
GreenPocket GmbH is a Cologne-based company specializing in energy management software for utility providers in Germany and internationally. Founded in 2009, the company focuses on the interpretation and visualization of smart metering energy consumption data. Its product suite includes the GreenPocket Solution for household customer portals, which visualize smart meter data for private consumers, as well as energy management software tailored for commercial clients. The company's offerings also encompass a smart home solution for efficient control of electrical appliances and energy monitoring tools, including online portals and applications that provide real-time energy consumption insights. Utilizing innovative technologies such as artificial intelligence and data science, GreenPocket aims to support the energy transition and digitalization of the energy sector by delivering intuitive and high-performance software solutions. With a track record of over 125 projects across 12 countries, GreenPocket positions itself as a trusted partner for utilities seeking to enhance their services and contribute to sustainability efforts.

Locr

Venture Round in 2010
Locr GmbH is a company based in Braunschweig, Germany, specializing in geo-based services and photo sharing. Founded in 2006, it operates an online platform that allows users to tag photos with location information through geotagging, enabling the visualization of these locations on maps and satellite images. Locr offers various geo-related products, including geo photography and geotagging software solutions, which help marketers leverage geographic data to enhance their marketing communications. By utilizing data from sources like OpenStreetMap, Locr provides personalized maps and geo-information services aimed at improving engagement and response rates for businesses and advertisers.

Bettermarks

Venture Round in 2010
Bettermarks GmbH, established in 2008 and headquartered in Berlin, Germany, specializes in an adaptive learning system for mathematics. It replaces traditional textbooks and exercise books, offering over 100 interactive math books for primary and secondary levels (grades 4-10, ages 10-16), covering topics like fractions, algebra, geometry, and more. The system provides more than 100,000 questions with detailed explanations, automatic marking, and result evaluation. It connects teachers, mathematicians, and software specialists to guide students through exercises systematically, offering constructive feedback and helping teachers manage diverse learning abilities in the classroom. The platform is available in German, English, and Spanish, providing a personalized learning experience that goes beyond simply indicating correct or incorrect answers, instead analyzing responses to detect errors and propose alternative solutions.

Galantos Pharma

Series C in 2010
Galantos Pharma GmbH is a biopharmaceutical company focused on developing innovative drugs for the treatment of Alzheimer's disease and other neurodegenerative disorders. Founded in 2005 and based in Mainz, Germany, the company is advancing Memogain, an investigational pro-drug derived from galantamine, a natural compound known for its use in Alzheimer's treatment. Memogain aims to provide both symptomatic relief and disease-modifying effects for patients with mild-to-moderate Alzheimer's dementia. Additionally, Galantos Pharma has established a technology platform designed for the screening and preclinical validation of drug candidates that interact with cholinergic and other neuro-receptors, as well as various brain enzymes, thereby contributing to the development of targeted therapies in the field of neurodegeneration.

clickworker

Series A in 2010
Clickworker GmbH is a leading provider of crowdsourcing solutions based in Essen, Germany, specializing in internet-based services both domestically and internationally. Founded in 2005, the company has built a large network of over 6 million freelancers, known as Clickworkers, across Europe, America, and Asia. Clickworker offers a wide range of services, including web research, text creation, categorization, surveys, and mobile crowdsourcing, all delivered in 18 languages and over 30 target markets. The company efficiently breaks down projects into micro tasks that are completed by qualified Clickworkers, ensuring high-quality results through a quality assurance process. Additionally, Clickworker provides a self-service marketplace for smaller tasks, enabling clients to access standardized solutions for text creation, surveys, and sentiment analysis. Its cloud platform enhances data management for e-commerce, offering services such as search engine optimization and data authentication, which help clients accelerate project execution and achieve cost savings. The company was previously known as humanGrid GmbH until its name change in 2013.

Cuculus

Series B in 2010
Cuculus GmbH, founded in 2007 and headquartered in Ilmenau, Germany, specializes in software solutions for the energy sector, particularly in smart metering and energy management. The company offers ZONOS, an IoT platform designed for smart metering, which facilitates the integration of electric, gas, and water meters with existing IT systems. Cuculus serves a diverse clientele that includes energy suppliers, grid operators, telecommunications companies, and metering service providers on a global scale. The firm leverages unique technology developed through collaborations with the Technical University Ilmenau and IDEO Laboratories, combining this with expertise in utilities and telecommunications. Additionally, Cuculus benefits from its location in a prominent technology region, providing access to innovative companies in automation, measurement engineering, and software development.

numares

Venture Round in 2009
numares AG is a German company that specializes in developing and marketing software-based test systems for clinical diagnostics and life science research. Founded in 2004 and headquartered in Regensburg, the company employs nuclear magnetic resonance (NMR) spectroscopy to create diagnostic tests that evaluate metabolomic networks. Its AXINON in vitro diagnostic (IVD) system produces a numeric spectrum that provides valuable insights into patients' disease statuses, assisting physicians in their evaluations. Utilizing magnetic group signaling (MGS) technology, numares focuses on diagnostics in areas such as cardiovascular diseases, nephrology, oncology, and neurology. The company is recognized as a leader in commercial NMR analytics in Europe, offering a comprehensive range of NMR-analytic services that are fast, cost-efficient, and reliable, enabling doctors to interpret complex metabolic patterns from blood and urine samples effectively.

Curetis

Series A in 2009
Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.

ELARA Pharmaceuticals

Series A in 2009
Elara Pharmaceuticals Gmbh provides research and pharmaceutical development services for new anti-cancer drugs. In addition Elara Pharmaceuticals Gmbh has discovered lead series of small, bioactive molecules that have anti-tumour activity, based on inhibitors of estrogen signaling and Aurora kinases. Elara Pharmaceuticals Gmbh was founded in 2006 and is based in Heidelberg, Germany.

Nevigo (Articy)

Private Equity Round in 2009
Nevigo GmbH, based in Bochum, Germany, specializes in developing a multi-platform game engine tailored for video games. The company provides a range of tools and middleware that enhance the creation of story-driven content, allowing developers to craft engaging gaming experiences. Its offerings include advanced compositing methods, a grading system, and a camera system, all aimed at improving the storytelling aspects of games. Through its innovative platform, Nevigo supports game developers in producing high-quality, immersive gameplay.

Stream5

Venture Round in 2009
Stream5 is a German video streaming company.

CorporateWorld

Series B in 2009
CorporateWorld GmbH operates a credit card based on-line travel management system for business travellers. It also offers travel management services. The company is based in Munich, Germany.

Metasonic

Venture Round in 2009
Metasonic AG is a Germany-based IT company founded in 2004 by Albert Fleischmann, specializing in enterprise software design and development. The company provides solutions centered around its core product, Metasonic Suite, which serves as a platform for subject-oriented business process management. This suite facilitates dynamic process applications, emphasizing communication and interaction among various participants within an organization, while also addressing elements of organizational culture. In addition to its software offerings, Metasonic provides a comprehensive range of training courses focused on business process management and the tools associated with Metasonic Suite. These training programs include standard sessions, certifications, and introductory courses on the S-BPM methodology. Metasonic collaborates with several international partners, including Alius Consulting Services, Binnova, Detecon, Devoteam, and GOMC Solutions, to enhance its service offerings and extend its market reach.

Novaled

Series C in 2009
Novaled AG is a leading technology provider specializing in organic light-emitting diode (OLED) technologies. Founded in March 2003 and headquartered in Dresden, Germany, the company develops high-efficiency, long-lifetime OLED structures, leveraging its expertise in synthetic and analytical chemistry. Novaled offers comprehensive solutions for the organic electronic markets, including customized OLED products and services used in various applications, such as televisions and mobile phones. The company has established long-term partnerships with major players in the OLED industry and holds a robust intellectual property portfolio, with over 500 patents granted or pending. Additionally, Novaled has branch offices in Asia to support its global operations.

Oxid eSales

Venture Round in 2008
OXID eSales AG is a prominent provider of multi-channel e-commerce solutions based in Freiburg, Germany, with an additional office in Halle. Founded in 2003, the company specializes in developing open-source shopping cart software, notably the OXID eShop platform. This platform caters to both B2B and B2C markets, offering scalable and customizable solutions that enhance online shopping experiences. OXID eSales serves a diverse clientele, including major brands like Lekkerland, Strenesse, Intersport, Gravis, and Deutsche Post, who benefit from the company’s extensive network of certified solution partners and dedicated support teams. The company's offerings also include the OXID eFire e-commerce intelligence platform, which streamlines online marketing, payment services, and intelligent search through a unified user interface. With a focus on innovation and quality, OXID eSales positions itself as a reliable partner for medium-sized businesses seeking to digitalize their sales processes and expand their market reach.

VIOSO

Series A in 2008
VIOSO GmbH, founded in 2007 and based in Düsseldorf, Germany, specializes in automatic digital edge-blending and geometry alignment solutions for various visual applications. The company offers a range of products, including VIOSO Player, a professional video playback software designed for custom screen surfaces like fulldome displays, and VIOSO Anyblend, an embedded warping and blending solution suitable for simulators, signage, and interactive experiences. VIOSO also provides technology for military and non-commercial simulators with its Anyblend VR & SIM product, as well as a media server solution, Wings VIOSO, for large venues and events. Additional offerings include high-resolution display solutions like VIOSO Blackbox 4K, autoalignment for video walls, and fulldome solutions for immersive content display. The company is committed to enhancing presentations and delivering innovative software solutions, leveraging expertise and experience gained since its inception.

Ubitexx

Series B in 2008
Ubitexx GmbH develops and distributes management and security software for smartphones and mobile devices. It offers ubi-Suite, a centralized smartphone management suite of capabilities. The company also provides strategic mobile management consulting, training and installation, and technical support services. It serves banking, insurance, pharmaceuticals, energy, media, engineering, and automotive industries, as well as public sector. Ubitexx GmbH was founded in 2002 and is based in Munich, Germany with an additional office in Cambridge, Massachusetts.

Phenex Pharmaceuticals

Series B in 2008
Phenex Pharmaceuticals AG is a privately held drug discovery and development company based in Ludwigshafen, Germany, with additional facilities in Heidelberg. Founded in 2002, the company specializes in small-molecule drug discovery, focusing on liver diseases, intestinal diseases, and cancer. Its research includes developing retinoid-acid receptor-related orphan receptor gamma t (RORγt) inverse agonists for autoimmune diseases and farnesoid X receptor (FXR) agonists for non-alcoholic steatohepatitis. Phenex aims to identify novel molecular mechanisms and develop innovative therapeutics, having already translated two such mechanisms into proprietary small molecules.

QuinLogic

Seed Round in 2008
QuinLogic is a pioneering German company specializing in quality assurance software tailored for steel and aluminum mills. Leveraging advanced computing power and storage capabilities, QuinLogic develops innovative solutions that facilitate industrial mass production while maintaining high flexibility. Their software is designed for ease of use and is actively utilized in several high-end flat rolling mills globally. It ensures reliable quality for various demanding markets, including automotive, aerospace, wind energy, and materials requiring high strength and wear resistance. Additionally, QuinLogic's software offers proactive support to swiftly address production issues, thereby reducing defects in customer products. The solution features seamless communication interfaces compatible with existing manufacturing execution systems, enterprise resource planning systems, and gauging systems, enabling full integration into both current and new production lines.

Signature Diagnostics

Series C in 2008
Signature Diagnostics GmbH is a translational oncology and genomics company based in Potsdam, Germany, founded in 2004. The company specializes in developing extensive biobanks of blood plasma and tumor tissue samples across various cancers, including colorectal and lung cancer, as part of large multicenter prospective clinical studies. A significant focus of Signature's work is on collecting longitudinal plasma samples from cancer patients to aid in research and treatment monitoring. Additionally, the company develops next-generation sequencing assays utilizing targeted gene panels and ultra-deep sequencing tests that leverage circulating free DNA (cfDNA). Signature Diagnostics aims to enhance the early detection and prognosis of cancer through its innovative molecular oncology diagnostic products and collaborations with clinical, pharmaceutical, and diagnostic partners.

Biontis

Venture Round in 2008
Biontis GmbH is a company based in Geesthacht, Germany, that specializes in the development of automated processes for biochemical analysis of complex liquid mixtures. Founded in 2002, Biontis produces a range of laboratory equipment and analytical procedures, including complete test kits, SPE columns, reagents, and devices designed to automate various analytical processes. Its products are utilized in diverse applications such as water analysis, food inspections, forensic medicine, and clinical diagnostics. By automating treatment steps like evaporation, heating, and dissolution, Biontis enables researchers to conduct innovative and cost-effective analytics, ensuring high-quality results in laboratory settings. The company primarily markets its offerings within Germany.

Locr

Angel Round in 2008
Locr GmbH is a company based in Braunschweig, Germany, specializing in geo-based services and photo sharing. Founded in 2006, it operates an online platform that allows users to tag photos with location information through geotagging, enabling the visualization of these locations on maps and satellite images. Locr offers various geo-related products, including geo photography and geotagging software solutions, which help marketers leverage geographic data to enhance their marketing communications. By utilizing data from sources like OpenStreetMap, Locr provides personalized maps and geo-information services aimed at improving engagement and response rates for businesses and advertisers.

DIVOLUTION

Venture Round in 2008
DIVOLUTION is a German company that offers testing and targeting technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.